Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8784821 Human-anti-human cd3 binding molecules

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

July 22, 2014

Patent Application Number

10554731

Date Filed

May 26, 2004

Patent Citations Received

US Patent 12129300 Antibody variable domains targeting the NKG2D receptor

0

US Patent 11976105 Antibody/T-cell receptor chimeric constructs and uses thereof

0

US Patent 11976125 B cell maturation antigen binding proteins

0

US Patent 12084518 Trispecific binding proteins and methods of use

0

US Patent 11834506 Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-associated antigen for activation of natural killer cells and therapeutic uses thereof to treat cancer

0

US Patent 11884733 Antibody variable domains targeting the NKG2D receptor

0

US Patent 11884732 Proteins binding HER2, NKG2D and CD16

0

US Patent 11939384 Antibody variable domains targeting the NKG2D receptor

0

...

Patent Primary Examiner

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8784821 Human-anti-human cd3 binding molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool